| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9319347 | European Urology | 2005 | 8 Pages |
Abstract
AR overexpression is an effective way of hormone refractory prostate cancer cells to overcome the growth inhibitory effects of elevated serum TGFbeta1 levels even in the absence of DHT. These findings provide an explanation for how AR overexpression favors growth in HRPC.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
H.G. van der Poel,